Latest News
Alert On Circulation Of Fake Coartem Tablets - Thursday, 28 December 2017 09:29
Warning On Homoeopathic Teething Tablets - Wednesday, 20 December 2017 15:04
Recall Of Rhino 7 Platinum 5000 Capsules - Wednesday, 20 December 2017 15:00
Recall Of Vancomycin Hydrochloride For Injection - Wednesday, 20 December 2017 14:44
Mislabeled Whole Foods Market Pb& J Parfait - Wednesday, 20 December 2017 14:34
Recall Of Man Of Steel 1 And 2 - Wednesday, 20 December 2017 14:22
Recall Of Lots Of Diocto Liquid And Diocto Syrup - Wednesday, 20 December 2017 14:08
Thursday, 05 November 2015 14:21


Rate this item
(1 Vote)

The National Agency for Food and Drug Administration and Control (NAFDAC) has been notified of the circulation of falsified Amoxverse and Ampiverse capsules in Democratic Republic of Congo (DRC). The notification was received from the World Health Organization (WHO) on 3rd November, 2015.

The Laboratory analysis of the products revealed that they do not contain any active ingredient. The purported manufacturer (UNIVERSE Ltd Kenya) stated on the label explained that they do not manufacture any Penicillin.

The falsified versions of the antibiotics labeled as manufactured by UNIVERSE Ltd Kenya are being circulated in plastic containers of 1000 capsules. It has been reported that these products have been found in private health care facilities in DRC.

The details of falsified products are:



Manufacturer: UNIVERSE Ltd Kenya

Trade name: AMOXVERSE

Product:  Amoxicillin 250mg

Batch Number: 21645

Manufacturing date: October, 2013

Expiry date: September, 2017

Presentation: Red and Orange Capsules of   250mg

Manufacturer: UNIVERSE Ltd Kenya

Trade name: AMPIVERSE

Product:   Ampicillin 250mg

Batch Number: 21645

Manufacturing date: October, 2013

Expiry date: September, 2017

Presentation: Red and Black Capsules of   250mg

NAFDAC hereby implores health care providers and the general public to be vigilant and ensure that any information in respect of importation, distribution or sale of the falsified Amoxverse and Ampiverse capsules is reported to the nearest NAFDAC office or the National Pharmacovigilance Center (NPC) via e-mail:  This email address is being protected from spambots. You need JavaScript enabled to view it.

NAFDAC…..Safeguarding the health of the Nation.

Read 14165 times Last modified on Wednesday, 18 May 2016 14:45



Contact Us from Mon - Friday: 08:00-16:00 GMT+1

Write Us:

NAFDAC Corporate Headquarters,

Plot 2032, Olusegun, Obasanjo Way,

Zone 7, Wuse, Abuja, Nigeria


Lagos Operation Office:

Plot 1, Industrial Estate, Lagos- Oshodi Apapa Express Way, Isolo, Lagos, Nigeria







For Enquiries:

Call: +234(0)-1-4609750












For Complaints:

Call: +234(0)909-763-0506


Or Send Us a Complaint










Contact Other NAFDAC Offices Nationwide